These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34949935)

  • 1. Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China.
    Wang Y; Peng L; Lu H; Zhang Z; Xing S; Li D; He C; Jin T; Wang L
    Pharmgenomics Pers Med; 2021; 14():1647-1660. PubMed ID: 34949935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.
    Zhang C; Guo W; Cheng Y; Li Q; Yang X; Dai R; Zhu L; Chen W
    Mol Genet Genomic Med; 2019 May; 7(5):e574. PubMed ID: 30955239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China.
    Li D; Peng L; Xing S; He C; Jin T
    BMC Genom Data; 2021 Nov; 22(1):51. PubMed ID: 34798807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of very important pharmacogene variants in the Chinese Lisu population.
    Lu H; Zhang Z; Wang Y; Wang L; Yuan D; He Y; Jin T
    Per Med; 2023 May; 20(3):239-249. PubMed ID: 37427690
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenomic landscape of VIP genetic variants in Jordanian Arabs and comparison with worldwide populations.
    Al-Eitan LN
    Gene; 2020 May; 737():144408. PubMed ID: 32007583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China.
    He Y; Yang H; Geng T; Feng T; Yuan D; Kang L; Luo M; Jin T
    Int J Clin Exp Pathol; 2015; 8(10):13293-303. PubMed ID: 26722533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of very important pharmacogene variants in the Tibetan population from China.
    Rong H; Dong H; He X; Yuan D; Bai M; Wang L; Liu T; He Y; Zheng J; Wang Y; Jin T
    Clin Exp Pharmacol Physiol; 2021 May; 48(5):668-678. PubMed ID: 32311112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of pharmacogenomic VIP variants in the Hui population from Ningxia Province of China.
    Zhou W; Guo J; Li Y; Ma X; Yang S; Wei J; Zhang H; Zhang S; Jin T
    Funct Integr Genomics; 2023 Mar; 23(2):85. PubMed ID: 36930384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population.
    He C; Peng L; Xing S; Li D; Wang L; Jin T
    Pharmgenomics Pers Med; 2021; 14():1027-1040. PubMed ID: 34429635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Variability of CYP4F2, CYP2D6, CYP2E1, and ACE in the Chinese Yi Population.
    Guo J; Zhou W; Ma X; Li Y; Zhang H; Wei J; Du S; Jin T
    Biochem Genet; 2024 Jun; ():. PubMed ID: 38850376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province.
    Cheng Y; Dai R; Chen W; Li Q; Zhang C; Yang T
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1231. PubMed ID: 32347657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations.
    Ma X; Li Y; Zang X; Guo J; Zhou W; Han J; Liang J; Wan P; Yang H; Jin T
    Cancer Chemother Pharmacol; 2024 May; 93(5):481-496. PubMed ID: 38300251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in very important pharmacogenomic (VIP) variants in the Tibetan population.
    Jin TB; Xun XJ; Shi XG; Yuan DY; Feng T; Geng TT; Kang LL
    Genet Mol Res; 2015 Oct; 14(4):12497-504. PubMed ID: 26505400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China.
    Chen W; Ding H; Cheng Y; Li Q; Dai R; Yang X; Zhang C
    Mol Genet Genomic Med; 2019 Sep; 7(9):e884. PubMed ID: 31361092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of pharmacogenomic VIP variants in the Lahu population from Yunnan Province.
    Dou X; Yang S; Zhang W; Meng W; Zhao W; Hao J; Hu X; Guo L; Jin T
    Gene; 2022 Nov; 844():146825. PubMed ID: 35995116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of pharmacogenomic VIP variants in the Kyrgyz population from northwest China.
    Yunus Z; Liu L; Wang H; Zhang L; Li X; Geng T; Kang L; Jin T; Chen C
    Gene; 2013 Oct; 529(1):88-93. PubMed ID: 23954225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very important pharmacogenetic variants landscape and potential clinical relevance in the Zhuang population from Yunnan province.
    Li Y; Chang Y; Yan Y; Ma X; Zhou W; Zhang H; Guo J; Wei J; Jin T
    Sci Rep; 2024 Mar; 14(1):7495. PubMed ID: 38553524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation of pharmacogenomic VIP variants in the Chinese Li population: an updated research.
    Yang S; Dou X; Wang Z; Zhang W; Ding K; Meng W; Li H; Liu J; Liu Y; Jin T
    Mol Genet Genomics; 2022 Mar; 297(2):407-417. PubMed ID: 35146537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of VIP variants in the Tajik ethnic group of northwest China.
    Zhang J; Jin T; Yunus Z; Li X; Geng T; Wang H; Cui Y; Chen C
    BMC Genet; 2014 Sep; 15():102. PubMed ID: 25266489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population genetic difference of pharmacogenomic VIP gene variants in the Lisu population from Yunnan Province.
    Zhang C; Jiang X; Chen W; Li Q; Yun F; Yang X; Dai R; Cheng Y
    Medicine (Baltimore); 2018 Dec; 97(52):e13674. PubMed ID: 30593137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.